King Faisal Specialist Hospital, Riyadh – United Arab Emirates
About Dr. Walid Rasheed
Dr. Walid Rasheed is a Consultant in Adult Hematology, Stem Cell Transplant & Cellular Therapy, specialising in lymphoma and multiple myeloma — a senior lymphoma / myeloma specialist in Riyadh, Saudi Arabia. He is a key member of the adult stem cell transplantation and cellular therapy programme.
- Consultant — Adult Hematology, Stem Cell Transplant & Cellular Therapy, Oncology Center
- Senior co-author on the international Worldwide Network for Blood & Marrow Transplantation (WBMT) cryopreservation-free SCT guidance (Bone Marrow Transplant 2025)
- Lead / co-author on multiple landmark papers in AYA acute lymphoblastic leukemia and Hodgkin lymphoma transplantation outcomes
- Co-lead on the KFSHRC AYA-15 pediatric-inspired protocol for adolescent/young adult ALL
- Corresponding author / senior author on multiple ASH and EBMT publications
Qualifications & Credentials
Medical Degrees
- MBBS / MD — Information not publicly available.
- Internal Medicine Residency — Information not publicly available.
- Adult Hematology Specialty Training — Information not publicly available.
Fellowships & Special Training
- Stem Cell Transplantation & Cellular Therapy Fellowship — Information not publicly available.
Certifications & Accreditations
- Information not publicly available.
- Saudi Commission for Health Specialties (SCFHS) registration
Areas of Expertise
Major Conditions Treated
- Multiple Myeloma
- Hodgkin Lymphoma
- Non-Hodgkin Lymphoma (including DLBCL)
- Acute Lymphoblastic Leukemia (AYA and adults)
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- Aplastic Anemia
- T-cell Acute Lymphoblastic Leukemia (T-ALL)
Sub-specialties
- Adolescent and Young Adult (AYA) ALL: Co-lead on the KFSHRC pediatric-inspired AYA-15 protocol — delivering best ALL treatment in Saudi Arabia for patients aged 14–55.
- Lymphoma & Myeloma Autologous SCT: Expert in autologous and allogeneic stem cell transplantation including cryopreservation-free protocols for resource-limited settings.
- Cellular Therapy Coordination: Integrated pathway for CAR-T cell therapy in relapsed/refractory lymphoma and leukemia.
Advanced Procedures & Treatments
- Autologous Stem Cell Transplantation
- Allogeneic Stem Cell Transplantation (matched sibling, unrelated, haploidentical)
- Non-Cryopreserved Autologous Peripheral Blood Stem Cell Transplant
- AYA Pediatric-Inspired ALL Chemotherapy Protocol
- Multiple Myeloma Induction, Maintenance, and Salvage Therapy
- Lymphoma Chemotherapy and Salvage Regimens
- CAR-T Cell Therapy Coordination
Professional Experience
Current Affiliation
- King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia — Consultant, Adult Hematology, Stem Cell Transplant & Cellular Therapy (Current)
Past Affiliations
- Information not publicly available.
Academic & Research Roles
- Collaborator — Worldwide Network for Blood & Marrow Transplantation (WBMT)
- Collaborator — Eastern Mediterranean Blood and Marrow Transplantation Group (EMBMT)
Key Achievements
- Senior author on the WBMT international guideline for non-cryopreserved PBSC transplantation in resource-limited settings
- Co-lead on landmark pediatric-inspired ALL protocol for AYA patients (14–55 years)
- Corresponding author on improved survival outcomes for T-ALL in adolescents and young adults
- Contributing author on Saudi myeloma working group consensus
Awards & Recognitions
National & International Awards
- Information not publicly available.
Professional Memberships
- American Society of Hematology (ASH)
- European Society for Blood and Marrow Transplantation (EBMT)
- Worldwide Network for Blood & Marrow Transplantation (WBMT)
- Eastern Mediterranean Blood and Marrow Transplantation Group (EMBMT)
Research & Publications
Published Papers (Selected)
- Bekadja MA, Niederwieser D, Kharfan-Dabaja MA, El Fakih R, Garderet L et al. (senior author Rasheed W). Non-cryopreserved autologous peripheral blood stem cell transplantation for multiple myeloma and lymphoma in countries with limited resources: practice considerations from the Worldwide Network for Blood and Marrow Transplantation. Bone Marrow Transplant. 2025;60(1):19-27. DOI: 10.1038/s41409-024-02431-y
- Hanbali A, Kotb A, Shihata N et al. Improved survival in adolescents and young adults (AYA) patients aged 14–55 years with acute lymphoblastic leukemia using pediatric-inspired protocol – a retrospective analysis. Leuk Res Rep. 2021;16:100238.
- Rasheed W, Ahmed SO, Shaheen M et al. Improved survival of adolescents and young adults patients with T-cell acute lymphoblastic leukemia. 2023 (PMC9979159).
- Akhtar S, Rasheed W et al. Stem cell collection in patients with relapsed or refractory diffuse large cell and Hodgkin's lymphoma using ESHAP + G-CSF: KFSH&RC experience. 2004.
Ongoing Research & Clinical Interests
- AYA acute lymphoblastic leukemia
- Non-cryopreserved stem cell transplantation
- Lymphoma and myeloma stem cell mobilisation
- Transplantation in resource-limited settings
Estimated Treatment Costs
| Procedure / Consultation | Estimated Cost (SAR) | Estimated Cost (USD) |
|---|---|---|
| Hematology / Transplant Consultation | SAR 500 – SAR 1,500 | $135 – $400 |
| Autologous Stem Cell Transplantation | SAR 150,000 – SAR 300,000 | $40,000 – $80,000 |
| Allogeneic Stem Cell Transplantation | SAR 300,000 – SAR 600,000 | $80,000 – $160,000 |
| Multiple Myeloma Therapy (per year) | SAR 150,000 – SAR 400,000 | $40,000 – $106,000 |
| AYA ALL Protocol (complete) | SAR 200,000 – SAR 500,000 | $53,000 – $133,000 |
*Indicative estimates only. Actual costs subject to hospital pricing, case complexity, and insurance. Contact Cancer Rounds for a personalised quote.
Frequently Asked Questions
1. What advanced technologies does Dr. Walid Rasheed use as a Hematologist?
Dr. Walid Rasheed uses the latest adult hematology therapies including non-cryopreserved peripheral blood stem cell transplantation, pediatric-inspired AYA-15 ALL protocol, advanced myeloma triplet/quadruplet regimens, and CAR-T cell therapy coordination. International consultations can be arranged via Cancer Rounds.
2. What conditions does Dr. Walid Rasheed specialize in treating?
Dr. Walid Rasheed treats multiple myeloma, Hodgkin and non-Hodgkin lymphoma, adolescent and young adult acute lymphoblastic leukemia (AYA ALL), acute myeloid leukemia, myelodysplastic syndromes, and aplastic anemia. He is a senior lymphoma / myeloma specialist in Riyadh consulted by international patients seeking stem cell transplantation.
3. How do I book an appointment with Dr. Walid Rasheed?
Appointments with Dr. Walid Rasheed can be booked directly through the Cancer Rounds website or by contacting their international patient department for priority scheduling.
4. Can international patients receive treatment from Dr. Walid Rasheed?
Yes. Cancer Rounds provides full assistance for international patients seeking treatment from Dr. Walid Rasheed, including Saudi Arabia medical visa invitation letters, airport transfers, and local accommodation coordination in Riyadh.
5. What support is available for international patients?
International patients benefit from a dedicated concierge service provided by Cancer Rounds, including language interpretation (Arabic, English, and more), financial counselling, and pre-travel virtual consultations to review medical records before arrival in Riyadh.
6. Does Dr. Walid Rasheed offer second opinions as a Hematologist?
Yes. Second opinion consultations can be arranged via Cancer Rounds for patients who wish to review their diagnosis or treatment plan with Dr. Walid Rasheed, an expert Hematologist in Riyadh, Saudi Arabia.
